Market Study Report LLC

Antidiabetics Market: Global Trends, Growth and Key Companies Analysis – Eli Lilly, Pfizer, Novo Nordisk, Takeda Pharmaceuticals, Sanofi Aventis, Merck

Market Study Report newly added the Global Antidiabetics Market Report evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2017-2024.


Selbyville, DE -- (SBWIRE) -- 11/09/2018 -- Japan antidiabetics market should grow at significant rate over the forecast period. Diabetic population is on rise due to lifestyle changes that will accompany economic growth and drive antidiabetic market growth. The Japan Diabetes Society (JDS) encourage progress and development of diabetes study and prevent people from disease in the country.

Some of the companies operating in antidiabetics market include Eli Lilly, Pfizer, Novo Nordisk, Takeda Pharmaceuticals, Sanofi Aventis, Merck, Boehringer Ingelheim and Oramed Pharmaceuticals.

Request a sample of this premium report at:

Long-acting insulin provide basal insulin coverage. Basal insulin suppresses hepatic gluconeogenesis and prevent increase in glucose level during fasting state in insulin-deficient patients. Long acting insulin analog includes insulin glargine (Lantus) and insulin detemir (Levemir) which will drive industry growth.
Antidiabetics Market is set to reach USD 110 billion by 2024; according to a new research report. Increasing number of obese and diabetic patients coupled with rising patient awareness levels serve as high impact rendering factors for antidiabetic market growth over the forecast period.

Rising geriatric population base, innovation of new drugs, increasing adoption of drugs and increased disposable income should further drive industry growth. Owing to the changes in lifestyle, even children between age group of 13-14 years are at high risk to get diabetes. It offers huge opportunities industry players.

U.S. antidiabetics market valued over USD 19.4 billion in 2016 and expected to grow significantly over the coming years. Increased healthcare expenditure along with availability of improved healthcare infrastructure and favorable reimbursement policies should drive antidiabetics market.

Advent of new technologies in products like long acting insulin analogs as well as rapid acting with increased effectiveness should drive industry growth over the forecast timeframe. The novel insulin pen technology permits low-pain and suitable daily insulin injection that should upsurge therapy sales. Type 2 diabetes mellitus (T2DM) has strong familial aggregation, the person with a parent or sibling with disease are at high risk. People with obesity, hypertension, or dyslipidemia and women with history of gestational diabetes are also at high risk to develop T2DM.

Request a discount on standard prices of this premium report at:

UK contributed for significant revenue share in 2016. The growth is attributed due to wide range of funds offered by Diabetes UK for research related to the treatment of diabetes and its complications. In November 2016, the Prime Minister introduced new Diabetes UK office on World Diabetes Day.

Table of Content:

Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. Antidiabetics Industry Insights
Chapter 4. Antidiabetics Market, By Product
Chapter 5. Antidiabetic Market, By Application
Chapter 6. Antidiabetics Market, By Region
Chapter 7. Company Profiles

For More Info On this Report At:

Related report:

Global Antidiabetics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
This report focuses on the Antidiabetics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

About Market Study Report allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Web site: